Summary
Autoantibodies to cardiolipin and intermediate filaments have both been reported with increased frequency in rheumatoid arthritis. We evaluated the frequency, pathological significance, and diagnostic relevance of these autoantibodies in a series of 124 patients and controls. We studied 81 patients with rheumatoid arthritis, 23 with osteoarthritis, and 20 normals. Antibodies to cardiolipin were measured by an ELISA method and antibodies to intermediate filaments were measured by indirect immunofluorescence using HEp2 cells. Antibodies to cardiolipin were present in 58% of rheumatoid patients and antibodies to intermediate filaments were present in 55% rheumatoid patients. They were both predominantly of IgM class, and were more frequent than in normal or osteoarthritic controls. Correlating levels of both these auto-antibodies to clinical and laboratory measures of disease activity such as Ritchie articular index and C-reactive protein level showed that no consistent relationships existed. They were not related to other auto-antibodies such as rheumatoid factors and antinuclear antibodies, nor to each other. These results show that antibodies to cardiolipin and intermediate filaments in rheumatoid arthritis are of no diagnostic value, they are not related to disease activity, and have no relationship to other autoimmune disturbances. We suggest that several pathological mechanisms must be involved in the development of auto-antibodies in rheumatoid arthritis.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ward, J., Johnson, D., Holborow, E.J. Antinuclear factor in rheumatoid arthritis, its incidence and clinical significance. Ann Rheum Dis 1964, 23, 306–310.
Osung, O.A., Chandra, M., Holborow, E.J. Antibody against 10nm filaments in rheumatoid arthritis. Ann Rheum Dis 1980, 38, 599–600.
Harris, E.N., Gharavi, A.E., Hughes, R.V. Antiphospholipid antibodies. Clin Rheum Dis 1985, 11, 591–609.
Keane, A., Wood, R., Dowding, V., Roden, D., Barry, C. Anti-cardiolipin antibodies in rheumatoid arthritis. Br J Rheumatol 1987, 26, 346–350.
Osung, O.A., Chandra, M., Holborow, E.J. Intermediate filaments in synovial lining cells in rheumatoid arthritis and other arthrides are of vimentin type. Ann Rheum Dis 1982, 41, 74–77.
Kurki, P., Virtanen, I., Stenman, S. Antibodies to cytoplasmic intermediate filaments in rheumatic disease. J Rheumatol 1983, 10, 558–562.
Ritchie, D.M., Boyle, J.A., McInnes, J.M. et al. Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q J Med 1968, 37, 393–406.
Bainbridge, D.R., Macey, M.M. Hoechst 33258: a fluorescent nuclear counterstain suitable for double-labelling immunofluorescence. J Immunol Methods 1983, 62, 193–195.
Loizou, S., McCrea, J.D., Rudge, A.C., Reynolds, R., Boyle, C.C., Harris, E.N. Measurement of anticardiolipin antibodies by an enzyme linked immuosorbent assay (ELISA): Standardisation and quantitation of results. Clin Exp Immunol 1985, 62, 738–745.
Harris, E.N., Gharavi, A.E., Hughes, G.R.V. Evaluation of the anticardiolipin test: report of an international workshop held 4th April 1986. Clin Exp Immunol 1986, 68, 215–222.
Harris, E.N., Gharavi, A.E., Boey, M.L. Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosis. Lancet 1983, ii, 1211–1214.
Gharavi, A.E., Harris, E.N., Asherson, R.A., Hughes, G.R.V. Anticardiolipin antibodies: isotype distribution and phospholipid specificity. Ann Rheum Dis 1987, 46, 1–6.
Harris, E.N., Gharavi, A.E., Wasley, G.D., Hughes, G.R.V. Use of an enzyme-linked immunosorbent assay and inhibition studies to distinguish between antibodies to cardiolipin from patients with syphilis of autoimmune disorders. J Infect Dis 1988, 157, 23–31.
Linder, E., Kurki, P., Anderson, L.C. Autoantibody to “Intermediate Filaments” in infectious mononucleosis. Clin Immunol Immunopathol 1979, 14, 411–417.
Fisher, C.L., Gill, C., Forrester, M.G., Nakamura, R. Quantitations of acute-phase proteins post operatively. Am J Pathol 1976, 66, 840–846.
Gaskin, F., Cantor, C.R., Shelanski, M.L. The biology of cytoplasmic microtubules. New York Acad Sci 1975, 75, 1333–1465.
Summerhayes, I.C., Wong, D., Chen, L.B. Effect of microtubules and intermediate filaments on mitochondrial distribution. J Cell Sci 1983, 61, 87–105.
Dioederichs, F., Millhams, K., Wittenborg, H., Trautsohold, M. Enzyme release from the perfused heart: the functions of the cytoskeleton under cell pathological conditions. J Clin Chem Clin Biochem 1986, 24, 3–9.
Linder, E. Binding of Clq and complement activation by vascular endothelium. J Immunol 1981, 126, 648–658.
Chellingworth, M.C., Salmon, M., Scott, D.L., Bacon, P.A. The significance of IgM antinuclear antibody in rheumatoid arthritis and other connective tissue diseases. Rheumatol Inter 1984, 4, 23–25.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jacobs, R., Butler, M.G. & Scott, D.L. Antibodies to cardiolipin and intermediate filaments: A study of autoimmunity in rheumatoid arthritis. Clin Rheumatol 9, 509–516 (1990). https://doi.org/10.1007/BF02030513
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02030513